Fusaroli M, Raschi E, Giunchi V, Menchetti M, Rimondini Giorgini R, Ponti F de et al. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse [...] 6. doi: 10.1093/ijnp/pyac031. Wolfschlag…
Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM et al. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry 2022;
verneint. Literatur Wittchen HU, Jacobi F, Rehm J et al.: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679. Bschor T: Definition [...] in the treatment of major depressive …
417-426. Brown KA, Samuel S, Patel DR: Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners. Transl Pediatr 2018; 7: 36-47.
Fu DJ, Ionescu DF, Li X et al.: Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study [...] Esketamine nasal spray for rapid reduction of…
recommended for hypotensive motility disorders in general. Relaxants of smooth muscle relieve symptoms only in part of the patients with hypertensive motility disorders including achalasia; however, study [...] und stellt Ärzte und Patienten vor rechtliche…
Neurol Clin 2009; 27: 321-334. GBD 2015 Neurological Disorders Collaborator Group: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Burden
inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000; 58: 19-36. Cipriani A, Furukawa TA, Salanti G et al.: Comparative efficacy and acceptability [...] ty of 21 antidepressant drugs for the acute…
ten-year atherosclerotic cardiovascular disease risk using new pooled cohort equations. BMC Cardiovasc Disord 2016; 16: 165. Angelow A, Klötzer C, Donner-Banzhoff N et al.: Validation of cardiovascular risk
be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000; 102: 1883–5. Straus SM, Sturkenboom MC, Bleumink GS, et al.: Non-cardiac QTc [...] 2012; 5 (10): A2. EMA, HMA: Pharmacovigilance…
2813. Autier P, Mullie P, Macacu A et al.: Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 2017: 5:
dopamine agonists. Mov Disord 2004; 19: 656–62. 3. Peralta C, Wolf E, Alber H et al.: Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study. Mov Disord 2006; 21: 1109–13. 4
Zugriff: 7. Juli 2020). Stand: 31. März 2020. Wakeman SE: Diagnosis and treatment of opioid use disorder in 2020: JAMA 2020; Epub ahead of print. doi: 10.1001/jama.2020.4104 vorab online Dieser Artikel
359-369. Greiner T, Haack B, Toto S et al.: Pharmacotherapy of psychiatric inpatients with adjustment disorder from 2000 to 2016. Eur Arch Psychiatry Clin Neurosci 2020; 270: 107-117. Raben AT, Marshe VS, Chintoh [...] et al.: Effectiveness of antipsychotic…
syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report. Ital J Pediatr 2020; 46: 169. Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco
die Kriterien des National Institute of Neurological and Communication Disorders and Stroke-Alzheimer Disease and Related Disorders Association angewandt. Eingeschlossen wurden Patienten mit einem Punktwert
es 1995 in einer ersten randomisierten kontrollierten Studie (National Institute of Neurological Disorder and Stroke [NINDS]) (1) nachzuweisen, dass beim Hirninfarkt die intravenöse systemische Thrombolyse [...] Tissue plasminogen activator for acute ischemic…
syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report. Ital J Pediatr 2020; 46: 169. Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco
Bryson WJ: Hypersomnia associated with isotretinoin in a patient with recurrent major depressive disorder and acne vulgaris. Sleep 2004; 27: 821. 3. Fachinformation Roaccutan® Weichkapseln, September 2004
Hamedifar H et al.: A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol 2019; 105: 107–115. Sastre J, Davila I: Dupilumab: A new paradigm for the treatment
Hamedifar H et al.: A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol 2019; 105: 107–115. Sastre J, Davila I: Dupilumab: A new paradigm for the treatment
Amin D, Cornell SA, Gustafson SK, Needle SJ et al.: Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. Journal of Lipid Research 1992; 33: 1657-1663
mplikationen, Thrombopenien und Anämien berichtet. Mit der standardisierten Recherche "Hepatic disorders" (Standardised MedDRA Query, SMQ) findet man 56 Berichte zu Lebererkrankungen im Zusammenhang mit
International Headache Society (IHS). Tension-type headache and migraine are the most common headache disorders, presenting usually with episodic headache, more rarely with chronic headache. The acute management [...] Committee of the International Headache…
muscle strength, radiographic knee osteoarthritis and knee pain: the ROAD study. BMC Musculoskelet Disord 2015; 16: 305. Riddle DL, Stratford PW: Body weight changes and corresponding changes in pain and
of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2002; 63: 763-71. 5. El-Sayed HG, Morganti C: Aripiprazole for schizophrenia
Neuropsychiatr Dis Treat 2018; 14: 3033-3035. Driot D, Chicoulaa B, Jouanjus E et al.: Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history. Therapie 2016; 71:
committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38: 1-211. Diener H-C, Gaul C, Kropp P et al.: Therapie der Mig
HJ, Stoppe G, Muller-Oerlinghausen B et al.: [Antipsychotics for treatment of neuropsychiatric disorders in dementia]. Nervenarzt 2013; 84: 370-373. Maust DT, Kim HM, Seyfried LS et al.: Antipsychotics
J Speech Lang Hear Res 2000; 43: 1264-1274. Allepaerts S, Delcourt S, Petermans J: Swallowing disorders in elderly patients: a multidisciplinary approach. Rev Med Liege 2014; 69: 349-356. Jungheim M,
model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. J Psychiatr Pract 2006; 12: 80-89. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
proven in a small subset of patients with suspected gluten intolerance. The pathophysiology of this disorder is not clearly understood, but most likely, not only gluten, but also additional grain compounds
presence of dermatitis herpetiformis rash, celiac disease, and low cholesterol. Prim Care Companion CNS Disord 2017; 19: 17l02134. Sarna VK, Lundin KEA, Morkrid L et al.: HLA-DQ-Gluten Tetramer Blood Test accurately
with an increase in morbidity and mortality (1;2). Depending on disease stage and severity, the disorder is presenting with a wide spectrum of symptoms. While underlying cause of hyponatremia may be manifold
Pharm 2017; 5: 197-201. Appleton KM, Sallis HM, Perry R et al.: ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review. BMJ Open 2016; 6: e010172. Arends J, Bachmann P, Baracos
insufficient data available or opioids are not recommended, e.g. in chronic headache and functional disorders (such as fibromyalgia, irritable bowel syndrome). It is important for all opioid applications that
terien der internationalen Kopfschmerzklassifikation (International Classification of Headache Disorders, ICHD-III). Eine Beschreibung der Studien findet sich unter: Erenumab ; Galcanezumab und Fremanezumab